How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

4,306 results for

Physical Medicine

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

4061. EANM procedure guideline for radio-immunotherapy for B-cell lymphoma with 90Y-radiolabelled ibritumomab tiuxetan (Zevalin)

University, Nijmegen Medical Centre, The Netherlands 9 Department of Nuclear Medicine, University Medical Centre, Maastricht, The Netherlands Corresponding author Jan Tennvall Department of Oncology, Lund University Hospital SE-221 85 Lund, Sweden Jan.Tennvall@med.lu.se Fax +46 46 17 60 80 Abstract. EMEA has approved 90 Y-radiolabelled ibritumomab tiuxetan, Zevalin ® , in Europe for the treatment of adult patients with rituximab-relapsed or -refractory CD20+ follicular B- cell non-Hodgkin´s lymphoma (NHL (...) ) in January 2004. The number of European nuclear medicine departments using Zevalin ® is continuously increasing, since the therapy is often considered successful. The Therapy-, the Oncology- and the Dosimetry Committees have worked together in order to define some EANM Guidelines on the use of Zevalin ® , paying particular attention to the problems related to Nuclear Medicine. The purpose of this guideline is to assist the nuclear medicine physician in treating and managing patients who may be candidates

2006 European Association of Nuclear Medicine

4062. Bone Scintigraphy

that the resources and facilities available to care for patients may vary from one country to another and from one medical institution to another. This document has been prepared primarily for nuclear medicine physicians and is intended to offer assistance in optimising the diagnostic information that can currently be obtained from bone scintigraphy. The corresponding guidelines from the Society of Nuclear Medicine (SNM) have been taken into consideration, reviewed and partial- ly integrated into this text (...) , University of Bonn, Germa- ny), Coakley A.J. (Department of Nuclear Medicine, Kent and Canterbury Hospital, Canterbury Kent, UK), Flux G. (Department of Physics, Royal Marsden Hospital, London, UK), Fogelman I. (Department of Nuclear Medicine, Guys Hospital, London, UK), Lassmann M. (Klinik für Nuklearmedizin, University of Würz- burg, Germany), Mather S.J. (Department of Nuclear Medicine, St. Bartholomew’s Hospital, London, UK), Merrick M.V. (Depart- ment of Nuclear Medicine, Western General Hospital

2003 European Association of Nuclear Medicine

4063. Guideline for Radioiodinated MIBG Scintigraphy in Children

years should receive 32 mg potassium iodide daily, from three to thirteen years 65 mg, and over this age 130 mg daily. New-borns receive 16 mg potassium iodide only on the day before tracer injection. Rapid blockade by perchlorate (Irenat) is an alternative option. B.3 Drugs interactions Many classes of medicines interfere with MIBG uptake and storage [21] . Treatment prescribed before and at the time of MIBG injection and imaging procedure should always be checked with the referring physician (...) . Unlike in adult patients, the list of usually concerned substances is actually limited. The most common are bronchodilators containing: Fenoterol (Berotec ®), Salbutamol (Ventolin®), Terbutaline (Bricanyl®) and nasal drops and sprays containing Xylometazoline (Otrivine drops®). The possibility of over the counter medicines should also be kept in mind. Many cardiac drugs interfere with MIBG and although such drugs are rarely found in a paediatric population, special attention should be paid to cases

2002 European Association of Nuclear Medicine

4064. EANM Procedure Guidelines for Radiosynovectomy

EANM Procedure Guidelines for Radiosynovectomy European Journal of Nuclear Medicine and Molecular Imaging Vol. 30, No. 1, January 2003 I. Purpose The purpose of this guideline is to assist nuclear medi- cine practitioners in 1. Evaluating patients who might be candidates for in- tra-articular treatment using colloidal preparations of 90 Y, 186 Re or 169 Er 2. Providing information regarding the performance of these treatments. 3. Understanding and evaluating the sequelae of therapy. II (...) procedures, by appropriately trained medical staff with supporting scientific and nursing staff. B. Patient preparation 1. Patients considered for intra articular 90 Y silicate/ci- trate, 186 Re sulphide or 169 Er citrate therapy will have failed at least one intra-articular injection of long-acting glucocorticoid (e.g. methylprednisolone acetate or triamcinolone). Pain will usually be severe enough to limit normal activities and/or require regular analgesics. 2. Radiographs of the joints to be treated

2002 European Association of Nuclear Medicine

4065. Evidence based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity

‘addiction’ to distinguish this syndrome from ‘dependence’ which would apply to those tolerant to at IMPERIAL COLLEGE LONDON on May 28, 2012 jop.sagepub.com Downloaded from Lingford-Hughes et al. 3 medication but not abusing or escalating its use. The criteria for the categories ‘harmful use’ (ICD-10) and ‘substance abuse’ (DSM-IV) differ, with the emphasis on negative social consequences of sub- stance use in the DSM classification, and on the physical and mental health consequences in the ICD-10 (...) ., 2005) (Ib), and equal to medical management (O’Malley et al., 2003) (Ib). Supportive therapy has been shown to be better than coping skills therapy (O’Malley et al., 1992) (Ib). In the COMBINE study, comparable outcomes resulted from combined behavioural intervention (CBI) alone, naltrexone, and the combination of CBI and naltrexone (Anton et al., 2006) (Ib). Broad spectrum treatment (BST) has been shown to result in better drinking outcomes than motiva- tional enhancement therapy (MET) only

2012 British Association for Psychopharmacology

4066. Brain Imaging using [18F]FDG

, Sweden S. Asenbaum Neurology, University Hospital Vienna, Vienna, Austria T. Vander Borght Nuclear Medicine Division, Université Catholique de Louvain, Mont-Godinne Medical Center, Mont-Godinne, Belgium J. Booij Department of Nuclear Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands F. Nobili Clinical Neurophysiology Unit, San Martino Hospital, University of Genova, Genova, Italy K. Någren Department of Clinical Physiology and Nuclear Medicine, Rigshospitalet (...) for 30 min to 1 h. If sedation is necessary it should be performed as late as possible. The intention should be to administer FDG prior to sedation. Eur J Nucl Med Mol Imaging– Informationabout(recent)morphologicalimagingstudies (CT,MRI),aswellasaboutfunctionalbrainexaminations (EEG, neuropsychology)inpeculiar conditions. – Current medication and when last taken, especially psychotropic pharmaceuticals. These may influence regional metabolic rate of glucose [19]. In parkinsonian patients

2009 European Association of Nuclear Medicine

4067. Revised American Thyroid Association Guidelines for DTC and Thyroid Nodule

, and other factors *Authors are listed in alphabetical order and were appointed by ATA to independently formulate the content of this manuscript. None of the scienti?c or medical content of the manuscript was dictated by the ATA. 1 The Johns Hopkins University School of Medicine, Baltimore, Maryland. 2 University of Michigan Medical Center, Ann Arbor, Michigan. 3 University of Colorado Health Sciences Center, Denver, Colorado. 4 The Ohio State University, Columbus, Ohio. 5 Boston University Medical (...) Center, Boston, Massachusetts. 6 University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania. 7 University of Florida College of Medicine, Gainesville, Florida. 8 The Mayo Clinic, Rochester, Minnesota. 9 The University of Siena, Siena, Italy. 10 Institute Gustave Roussy, Paris, France. 11 University of Texas M.D. Anderson Cancer Center, Houston, Texas. 12 University of Cincinnati Medical Center, Cincinnati, Ohio. 13 Memorial Sloan-Kettering Cancer Center, New York, New York. THYROID

2009 British Association of Endocrine and Thyroid Surgeons

4068. EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology

, Leiden, The Netherlands 7 Nuklearmedizinische Klinik der TU, Munich, Germany 8 Department of Nuclear Medicine, Academic Medical Center, Amsterdam, The Netherlands 9 Department of Medical Physics, Hull and East Yorkshire Hospitals NHS Trust, Hull, UK 10 Nuclear Medicine Section, Division of Human Health, International Atomic Energy Agency, Vienna, Austria 11 Nuclear Medicine, AZ VUB, Brussels, Belgium 12 Turku PET Centre, Turku University Central Hospital, Turku, Finland 13 Klinik fu ¨r Nuklearmedizin (...) , Universita ¨tWu ¨rzburg, Wu ¨rzburg, Germany 14 Department of Medical Radiation Physics, The Jubileum Institute, Lund, Sweden 15 Fondazione Maugeri, IRCCS, Verona, Italy 16 Service de Me ´decine Nucle ´aire, Ho ˆpital de Brabois, Vandoeuvre, France 17 Nuclear Medicine Department, Aberdeen Royal Infirmary, Foresterhill Scotland, UK 18 Section of Nuclear Medicine, Mayo Clinic, Rochester MN, US 19 Institute of Nuclear Medicine, Middlesex Hospital, London, UK 20 Department of Nuclear Medicine, Royal Brompton

2005 European Association of Nuclear Medicine

4069. Breast Scintigraphy

-bis bis(2- ethoxy-ethylphosphine)ethane) breast scintigraphy protocols used in the current clinical routine. The guideline should therefore not be taken as exclusive of other nuclear medicine procedures useful to obtain comparable results. It is important to remember that the resources and the facilities available for patient care may vary from one country to another and from one medical institution to another. The present guide has been prepared for nuclear medicine physicians and intends (...) a thorough explanation of the test. The patient should remove all clothing and jewellery above the waist immediately prior to the examination. 2) Pre-injection Clinical evaluation by the nuclear medicine physician The nuclear medicine physician should perform an accurate breast physical examination to evaluate the abnormalities under study. Also the locoregional lymph nodes should be explored. In addition, the physician should consider any information that can be useful for the interpretation

2003 European Association of Nuclear Medicine

4070. Non-epithelial ovarian cancer

Non-epithelial ovarian cancer Non-epithelialovariancancer:ESMOClinical PracticeGuidelinesfordiagnosis,treatment andfollow-up † N. Colombo 1,5 , M. Peiretti 1 , A. Garbi 1 , S. Carinelli 2,4 , C. Marini 5 & C. Sessa 3,4 , on behalf of the ESMO Guidelines Working Group * Departments of 1 Gynecologic Oncology; 2 Pathology, European Institute of Oncology, Milan, Italy; 3 Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; 4 Unit of New Drugs & Innovative Therapies, Department (...) of Medical Oncology, San Raffaele Hospital, O.U. Medicine 1Q-A Fondazione Centro San Raffaele del Monte Tabor, Milan, Italy; 5 Department of Gynecologic Oncology, Università Milano-Bicocca, Milan, Italy incidenceandepidemiology Non-epithelial malignancies of the ovary account for~10% of all ovarian cancers [1]. Germ cell tumors (GCTs) are diagnosed principally in the ?rst two decades of life, whereas sex cord-stromal tumors (SCSTs) are more common in adult women (granulosa adult type has an average age

2012 European Society for Medical Oncology

4071. EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds

for combined therapy/sequence with chemo- therapy and other anti-cancer drugs [39–41] 6. Validation of treatment planning techniques in predict- ing therapeutic efficacy and preventing toxicity Disclaimer The EANM has written and approved guidelines to promote the cost-effective use of high-quality nuclear medicine therapeutic procedures. These generic recommen- dations cannot be rigidly applied to all patients in all practice settings. The guidelines should not be deemed inclusive of all proper procedures (...) Hospital Basel, Basel, Switzerland F. Kraeber-Bodere University hospital, Rene Gauducheau cancer center, CRCNA unit 892, Nantes, France B. Brans Department of Nuclear Medicine, University Medical Center Maastricht, Maastricht, The Netherlands B. Lambert Department of Nuclear Medicine, Ghent University Hospital, Ghent, Belgium M. Konijnenberg Nuclear Medicine Department, Erasmus MC, Rotterdam, The Netherlands F. Borson-Chazot Hospices Civils de Lyon, Fédération d’endocrinologie, Université Lyon 1

2011 European Association of Nuclear Medicine

4072. Guidelines for standard and diuretic renogram in children

for national and international legal or regulatory provisions. This guideline has been brought to the attention of the National Societies of Nuclear Medicine. The guidelines have been reviewed by the EANM Dosimetry Committee, the EANM Physics Committee and the EANM Radiopharmacy Committee. Purpose The purpose of this guideline is to offer to the nuclear medicine team a framework, which could prove helpful in daily practice. This guideline contains information related to the acquisition, processing (...) . The pitfalls, difficulties and controversies that are encountered are also discussed, as well as the interpretation of the results. Keywords Children . Renography . Diuretic . Obstruction Disclaimer This guideline summarises the views of the Paediatric Committee of the European Association of Nuclear Med- icine (EANM) and reflects recommendations for which the EANM cannot be held responsible. These recommenda- tions should be taken in the context of “good practice” of nuclear medicine and do not substitute

2011 European Association of Nuclear Medicine

4073. Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada : Diabetes in the elderly

in the older adult (see below) and since there is no evidence that preventing diabetes will make a difference in outcomes in these people, there would appear to be little justification for drug therapy to prevent diabetes in older adults. Table 1 Glycemic targets in older people with diabetes A1C, glycated hemoglobin ; CBGM , capillary blood glucose monitoring; SU , sulfonylurea. * Clinical Frailty Score (1 - very fit to 9 - terminally ill). Please see . Status Functionally independent Functionally (...) and remediation of medically urgent situations, as well as reduce hospitalizations . A pharmaceutical care program (e.g. monitoring of symptoms, medication counselling, facilitating communications with physicians/nurse practitioners by pharmacists) can significantly improve medication compliance, as well as the control of diabetes and its associated risk factors (see Organization of Care chapter, p.S27). Self-management education and support Self-management education and support programs are a vital aspect

2013 CPG Infobase

4074. Obstetric Anaesthetic Services

should be undertaken and arrangements made for pre-operative preparation (fasting, antacid therapy and any other medication that should be given or withheld). This pre-operative assessment and preparation may be led by midwifery or other appropriate staff, but an anaesthetist must be available to provide advice and, if necessary, to review patients during this process. The process for such pre- assessment services must include anaesthetic input and review. Women should be assessed by an anaesthetist (...) should be recorded on admission for all women admitted to maternity units, including midwifery-led units. A graded response strategy for patients identified as being at risk 15 of clinical deterioration, as recommended by the Maternity Critical Care Working Party [3], should be agreed and delivered locally. It is widely recognised that the quality of evidence for track-and-trigger systems in any area of medicine is limited. Such systems allowing a graded medical response can be based on aggregate

2013 Association of Anaesthetists of GB and Ireland

4075. Lactational mastitis and breast abscess. Diagnosis and management in general practice

, FASbP , is a breast physician, The Poche Centre, north Sydney and Clinical Senior Lecturer, northern Clinical School, Sydney Medical School, university of Sydney, new South Wales. Conflict of interest: none declared. References 1. Academy of breastfeeding Medicine Protocol Committee. AbM Clinical Protocol #4: Mastitis. Revision, May 2008. breastfeed Med 2008;3:177–80. 2. Amir Lh. breast pain in lactating women: mastitis or something else? Aust Fam Physician 2003;32:141–5. 3. Amir Lh, Forster DA (...) and S. epidermidis. Patients who suffer with recurrent breast abscesses have a higher incidence of mixed flora, including anaerobic organisms. 5 On rare occasions Candida albicans, not an uncommon cause of nipple pain in lactating women, 9 can cause parenchymal infection. 12 Clinical assessment History and physical examination breast pain is the primary symptom of mastitis. 7 high fever is common, along with other generalised flu-like symptoms including malaise, lethargy, myalgia, sweating, headache

2011 Clinical Practice Guidelines Portal

4076. Exercise and Sports Science Australia position statement on exercise and falls prevention in older people

to explore the effectiveness of a range of fall prevention strategies. This statement has utilised this high quality evidence to provide guidance on effective exercise prescription for the prevention of falls in older community- dwelling people. 2. Role of exercise for prevention of falls The de?nitions of exercise and physical activity used in the American College of Sports Medicine (ACSM) Position Stand on Exercise and Physical Activity for Older Adults were used in this paper. 15 Physical activity (...) It is widely acknowledged that physical activity has wide ranging bene?ts for the health and well-being of people of all ages. Physical activity can reduce the risk of developing certain diseases and can play a role in the management and control of many chronic medical conditions such as arthritis, diabetes, heart and respiratory conditions 26 and can slow the decline in mobility in cognitively impaired older people. 27 The ACSM and the American Heart Association (AHA) physical activity recommendation

2011 Clinical Practice Guidelines Portal

4077. Clinical practice guidelines for surveillance colonoscopy - in adenoma follow-up; following curative resection of colorectal cancer; and for cancer surveillance in inflammatory bowel disease (December 2011)

represents the National Health and Medical Research Council's position on the matters contained therein. An updated version of this guideline is in progress. This version has been available for reference purposes only until the revised guidelines are available. This project was partially funded by the Australian Government Department of Health and Ageing under the National Bowel Cancer Screening Program. © Cancer Council Australia 2011 This work is copyright. You may download, display, print (...) __________________________________________________________________________________________ Publication Approval These guidelines were approved by the Chief Executive Officer of the National Health and Medical Research Council (NHMRC) on 8 December 2011, under Section 14A of the National Health and Medical Research Council Act 1992. In approving these guidelines the NHMRC considers that they meet the NHMRC standard for clinical practice guidelines. This approval is valid for a period of five years. NHMRC is satisfied that they are based on the systematic identification and synthesis of the best

2011 Clinical Practice Guidelines Portal

4078. Australian Association for Exercise and Sports Science position statement on exercise and asthma

possible. A speci?c bene?t of a physical training program is that it allows asthmatics to exercise with less bronchoconstriction at the same exercise stress, although it does not abolish or reduce airway hyperresponsiveness (AHR). © 2011 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved. Keywords: Exercise; Asthma; Asthma medications; Exercise-induced asthma; Physical activity Contents 1. Introduction 312 2. Role of exercise in the treatment of asthma 314 3. Exercise (...) to determine if after cessation of endurance training in such316 A.R. Morton, K.D. Fitch / Journal of Science and Medicine in Sport 14 (2011) 312–316 environments, the AHR will cease, as shown in elite Finnish swimmers. 29 7. Conclusions Although exercise can induce EIB, regular physical activ- ity is an important component in the management of asthma. It is critical to obtain adequate control of asthma with con- troller medication to minimise EIB. All asthmatics should have and adhere to a personalised

2011 Clinical Practice Guidelines Portal

4079. Australian Association for Exercise and Sports Science position statement on exercise and asthma Full Text available with Trip Pro

Pathology and Medical Research, Sydney, NSW. 9 Royal Hobart Hospital, Hobart, TAS. 10 Clinical Microbiology Laboratory, LabPlus, Auckland District Health Board, Auckland, NZ. 11 Infectious Diseases, Monash Medical Centre, Melbourne, VIC. 12 Microbiology and Immunology, University of Western Australia, Perth, WA. 13 Division of Microbiology and Infectious Diseases, PathWest Laboratory Medicine WA, Perth, WA. Correspondence: Acknowledgements: We thank Anton Peleg, Paul Johnson, Chris Lemoh, Kate Cherry (...) Australian Association for Exercise and Sports Science position statement on exercise and asthma Australasian Society for Infectious Diseases guidelines for the diagnosis and treatment of Clostridium difficile infection | The Medical Journal of Australia mja-search search Use the for more specific terms. Title contains Body contains Date range from Date range to Article type Author's surname Volume First page doi: 10.5694/mja__.______ Search Reset  close Individual Login Purchase options

2011 Clinical Practice Guidelines Portal

4080. Guidelines for the prescription of a seated wheelchair or mobility scooter for people with a traumatic brain injury or spinal cord injury

and risk of injury 32 7.6.1 Upper limb capacity 32 7.6.2 Upper limb injury 34 7.7 Cardiovascular fitness 39 7.8 Co-morbid conditions 39 7.9 Alcohol, prescribed medications and illicit drug use. 40 7.10 Long-term need 40 7.11 Health and safety concerns 41 7.12 Two wheelchairs 45 Guidelines for the prescription of a seated wheelchair or mobility scooter for people with a traumatic brain injury or spinal cord injury 6 8. Wheelchair features 46 8.1 Pressure management 46 8.2 Ride and comfort 47 8.3 Tilt (...) for people with a traumatic brain injury or spinal cord injury This publication is endorsed by Occupational Therapy (OT) Australia – NSW Division You may copy, distribute, display and otherwise freely deal with this work for any purpose, provided that you attribute the LTCSA and EnableNSW as the owners. However, you must obtain permission if you wish to (1) charge others for access to the work (other than at cost), (2) include the work in advertising or a product for sale, or (3) modify the work. ISBN

2011 Clinical Practice Guidelines Portal

Guidelines

Guidelines – filter by country